HEADER TRANSFERASE 31-MAY-18 6GNU TITLE CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N-MYRISTOYLTRANSFERASE (NMT) TITLE 2 WITH BOUND MYRISTOYL-COA AND A QUIONLINYL ARYL SULPHONAMIDE LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 EC: 2.3.1.97; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LEISHMANIA MAJOR; SOURCE 3 ORGANISM_TAXID: 5664; SOURCE 4 GENE: NMT, LMJF_32_0080; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ACYLTRANSFERASE, TRANSFERASE, DRUG DISCOVERY EXPDTA X-RAY DIFFRACTION AUTHOR D.A.ROBINSON,J.R.HARRISON,S.BRAND,V.C.SMITH,S.THOMPSON,A.SMITH, AUTHOR 2 K.DAVIES,N.Y.MOK,L.S.TORRIE,I.COLLIE,I.HALLYBURTON,S.NORVAL, AUTHOR 3 F.R.C.SIMEONS,L.STOJANOVSKI,J.A.FREARSON,R.BRENK,P.G.WYATT, AUTHOR 4 I.H.GILBERT,K.D.READ REVDAT 3 17-JAN-24 6GNU 1 REMARK REVDAT 2 10-OCT-18 6GNU 1 JRNL REVDAT 1 26-SEP-18 6GNU 0 JRNL AUTH J.R.HARRISON,S.BRAND,V.SMITH,D.A.ROBINSON,S.THOMPSON, JRNL AUTH 2 A.SMITH,K.DAVIES,N.MOK,L.S.TORRIE,I.COLLIE,I.HALLYBURTON, JRNL AUTH 3 S.NORVAL,F.R.C.SIMEONS,L.STOJANOVSKI,J.A.FREARSON,R.BRENK, JRNL AUTH 4 P.G.WYATT,I.H.GILBERT,K.D.READ JRNL TITL A MOLECULAR HYBRIDIZATION APPROACH FOR THE DESIGN OF POTENT, JRNL TITL 2 HIGHLY SELECTIVE, AND BRAIN-PENETRANT N-MYRISTOYLTRANSFERASE JRNL TITL 3 INHIBITORS. JRNL REF J. MED. CHEM. V. 61 8374 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30207721 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00884 REMARK 2 REMARK 2 RESOLUTION. 1.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 56088 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.158 REMARK 3 R VALUE (WORKING SET) : 0.157 REMARK 3 FREE R VALUE : 0.185 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2985 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.54 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.58 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3529 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.41 REMARK 3 BIN R VALUE (WORKING SET) : 0.2110 REMARK 3 BIN FREE R VALUE SET COUNT : 182 REMARK 3 BIN FREE R VALUE : 0.2470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3337 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 98 REMARK 3 SOLVENT ATOMS : 270 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.08000 REMARK 3 B22 (A**2) : -0.07000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.01000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.074 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.075 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.050 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.372 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.967 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3545 ; 0.025 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3319 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4836 ; 2.403 ; 1.984 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7591 ; 1.515 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 412 ; 6.891 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 169 ;33.429 ;23.669 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 554 ;15.469 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;20.530 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 508 ; 0.148 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3950 ; 0.012 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 831 ; 0.008 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6GNU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1200010303. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5-6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59093 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.540 REMARK 200 RESOLUTION RANGE LOW (A) : 48.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.03900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.54 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.36400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3H5Z REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26%PEG1500,0.2M NACL, 0.1M REMARK 280 NACACODYLATE, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 44.96700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1620 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -16 REMARK 465 GLY A -15 REMARK 465 SER A -14 REMARK 465 SER A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 SER A -6 REMARK 465 SER A -5 REMARK 465 GLY A -4 REMARK 465 ARG A -3 REMARK 465 GLU A -2 REMARK 465 ASN A -1 REMARK 465 LEU A 0 REMARK 465 TYR A 1 REMARK 465 PHE A 2 REMARK 465 GLN A 3 REMARK 465 GLY A 4 REMARK 465 PRO A 5 REMARK 465 SER A 6 REMARK 465 ASN A 7 REMARK 465 SER A 8 REMARK 465 ASP A 9 REMARK 465 ALA A 10 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 233 OG REMARK 470 ILE A 235 CG1 CG2 CD1 REMARK 470 GLN A 240 CG CD OE1 NE2 REMARK 470 LYS A 241 CG CD CE NZ REMARK 470 GLN A 243 CG CD OE1 NE2 REMARK 470 SER A 336 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB SER A 86 O HOH A 605 1.53 REMARK 500 CB SER A 221 O HOH A 601 1.55 REMARK 500 CB GLU A 147 O HOH A 613 1.78 REMARK 500 CD GLU A 48 O HOH A 602 1.85 REMARK 500 OG SER A 221 O HOH A 601 2.05 REMARK 500 SD MET A 141 O HOH A 852 2.07 REMARK 500 CB ASN A 315 O HOH A 612 2.07 REMARK 500 O HOH A 761 O HOH A 837 2.07 REMARK 500 OE2 GLU A 48 O HOH A 602 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 147 CD GLU A 147 OE2 0.083 REMARK 500 LYS A 268 CA LYS A 268 CB 0.188 REMARK 500 LYS A 268 CD LYS A 268 CE -0.152 REMARK 500 ASP A 316 CB ASP A 316 CG -0.145 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 67 CB - CG - OD1 ANGL. DEV. = 5.4 DEGREES REMARK 500 ARG A 89 CD - NE - CZ ANGL. DEV. = 17.7 DEGREES REMARK 500 ARG A 89 NE - CZ - NH1 ANGL. DEV. = 19.7 DEGREES REMARK 500 ARG A 89 NE - CZ - NH2 ANGL. DEV. = -16.9 DEGREES REMARK 500 ARG A 134 NE - CZ - NH2 ANGL. DEV. = -4.4 DEGREES REMARK 500 ASP A 158 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 ARG A 191 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG A 194 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 LYS A 268 CA - CB - CG ANGL. DEV. = 23.2 DEGREES REMARK 500 ASP A 284 CB - CG - OD1 ANGL. DEV. = 7.4 DEGREES REMARK 500 ASP A 287 CB - CG - OD2 ANGL. DEV. = -7.3 DEGREES REMARK 500 ARG A 304 CG - CD - NE ANGL. DEV. = -15.5 DEGREES REMARK 500 GLU A 388 OE1 - CD - OE2 ANGL. DEV. = 7.5 DEGREES REMARK 500 ASP A 396 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 53 152.21 -47.16 REMARK 500 MET A 135 33.74 -149.44 REMARK 500 ILE A 163 -169.96 -122.97 REMARK 500 SER A 233 32.66 -77.63 REMARK 500 VAL A 307 -63.15 -124.16 REMARK 500 HIS A 347 -143.00 -106.58 REMARK 500 GLU A 379 40.88 -77.09 REMARK 500 LEU A 381 -142.54 54.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE A 232 SER A 233 -39.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MYA A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F5Z A 502 DBREF 6GNU A 5 421 UNP Q4Q5S8 Q4Q5S8_LEIMA 5 421 SEQADV 6GNU MET A -16 UNP Q4Q5S8 INITIATING METHIONINE SEQADV 6GNU GLY A -15 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU SER A -14 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU SER A -13 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU HIS A -12 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU HIS A -11 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU HIS A -10 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU HIS A -9 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU HIS A -8 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU HIS A -7 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU SER A -6 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU SER A -5 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU GLY A -4 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU ARG A -3 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU GLU A -2 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU ASN A -1 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU LEU A 0 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU TYR A 1 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU PHE A 2 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU GLN A 3 UNP Q4Q5S8 EXPRESSION TAG SEQADV 6GNU GLY A 4 UNP Q4Q5S8 EXPRESSION TAG SEQRES 1 A 438 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 438 ARG GLU ASN LEU TYR PHE GLN GLY PRO SER ASN SER ASP SEQRES 3 A 438 ALA ALA HIS ALA PHE TRP SER THR GLN PRO VAL PRO GLN SEQRES 4 A 438 THR GLU ASP GLU THR GLU LYS ILE VAL PHE ALA GLY PRO SEQRES 5 A 438 MET ASP GLU PRO LYS THR VAL ALA ASP ILE PRO GLU GLU SEQRES 6 A 438 PRO TYR PRO ILE ALA SER THR PHE GLU TRP TRP THR PRO SEQRES 7 A 438 ASN MET GLU ALA ALA ASP ASP ILE HIS ALA ILE TYR GLU SEQRES 8 A 438 LEU LEU ARG ASP ASN TYR VAL GLU ASP ASP ASP SER MET SEQRES 9 A 438 PHE ARG PHE ASN TYR SER GLU GLU PHE LEU GLN TRP ALA SEQRES 10 A 438 LEU CYS PRO PRO ASN TYR ILE PRO ASP TRP HIS VAL ALA SEQRES 11 A 438 VAL ARG ARG LYS ALA ASP LYS LYS LEU LEU ALA PHE ILE SEQRES 12 A 438 ALA GLY VAL PRO VAL THR LEU ARG MET GLY THR PRO LYS SEQRES 13 A 438 TYR MET LYS VAL LYS ALA GLN GLU LYS GLY GLU GLY GLU SEQRES 14 A 438 GLU ALA ALA LYS TYR ASP GLU PRO ARG HIS ILE CYS GLU SEQRES 15 A 438 ILE ASN PHE LEU CYS VAL HIS LYS GLN LEU ARG GLU LYS SEQRES 16 A 438 ARG LEU ALA PRO ILE LEU ILE LYS GLU ALA THR ARG ARG SEQRES 17 A 438 VAL ASN ARG THR ASN VAL TRP GLN ALA VAL TYR THR ALA SEQRES 18 A 438 GLY VAL LEU LEU PRO THR PRO TYR ALA SER GLY GLN TYR SEQRES 19 A 438 PHE HIS ARG SER LEU ASN PRO GLU LYS LEU VAL GLU ILE SEQRES 20 A 438 ARG PHE SER GLY ILE PRO ALA GLN TYR GLN LYS PHE GLN SEQRES 21 A 438 ASN PRO MET ALA MET LEU LYS ARG ASN TYR GLN LEU PRO SEQRES 22 A 438 SER ALA PRO LYS ASN SER GLY LEU ARG GLU MET LYS PRO SEQRES 23 A 438 SER ASP VAL PRO GLN VAL ARG ARG ILE LEU MET ASN TYR SEQRES 24 A 438 LEU ASP SER PHE ASP VAL GLY PRO VAL PHE SER ASP ALA SEQRES 25 A 438 GLU ILE SER HIS TYR LEU LEU PRO ARG ASP GLY VAL VAL SEQRES 26 A 438 PHE THR TYR VAL VAL GLU ASN ASP LYS LYS VAL THR ASP SEQRES 27 A 438 PHE PHE SER PHE TYR ARG ILE PRO SER THR VAL ILE GLY SEQRES 28 A 438 ASN SER ASN TYR ASN LEU LEU ASN ALA ALA TYR VAL HIS SEQRES 29 A 438 TYR TYR ALA ALA THR SER ILE PRO LEU HIS GLN LEU ILE SEQRES 30 A 438 LEU ASP LEU LEU ILE VAL ALA HIS SER ARG GLY PHE ASP SEQRES 31 A 438 VAL CYS ASN MET VAL GLU ILE LEU ASP ASN ARG SER PHE SEQRES 32 A 438 VAL GLU GLN LEU LYS PHE GLY ALA GLY ASP GLY HIS LEU SEQRES 33 A 438 ARG TYR TYR PHE TYR ASN TRP ALA TYR PRO LYS ILE LYS SEQRES 34 A 438 PRO SER GLN VAL ALA LEU VAL MET LEU HET MYA A 501 63 HET F5Z A 502 35 HETNAM MYA TETRADECANOYL-COA HETNAM F5Z 4-[4-(1-METHYLPIPERIDIN-4-YL)BUTYL]-~{N}-[6-(2- HETNAM 2 F5Z METHYLPROPYL)QUINOLIN-5-YL]BENZENESULFONAMIDE HETSYN MYA MYRISTOYL-COA FORMUL 2 MYA C35 H62 N7 O17 P3 S FORMUL 3 F5Z C29 H39 N3 O2 S FORMUL 4 HOH *270(H2 O) HELIX 1 AA1 PHE A 14 GLN A 18 5 5 HELIX 2 AA2 THR A 23 ILE A 30 1 8 HELIX 3 AA3 THR A 41 ILE A 45 5 5 HELIX 4 AA4 ALA A 65 TYR A 80 1 16 HELIX 5 AA5 SER A 93 CYS A 102 1 10 HELIX 6 AA6 ILE A 107 ASP A 109 5 3 HELIX 7 AA7 PRO A 138 LYS A 148 1 11 HELIX 8 AA8 GLU A 150 LYS A 156 1 7 HELIX 9 AA9 LYS A 173 ARG A 176 5 4 HELIX 10 AB1 ARG A 179 ARG A 194 1 16 HELIX 11 AB2 ASN A 223 SER A 233 1 11 HELIX 12 AB3 PRO A 236 GLN A 240 5 5 HELIX 13 AB4 ASN A 244 GLN A 254 1 11 HELIX 14 AB5 LYS A 268 SER A 270 5 3 HELIX 15 AB6 ASP A 271 ASP A 284 1 14 HELIX 16 AB7 SER A 293 LEU A 302 1 10 HELIX 17 AB8 PRO A 355 ARG A 370 1 16 HELIX 18 AB9 ASP A 382 VAL A 387 5 6 HELIX 19 AC1 LYS A 412 VAL A 416 5 5 SHEET 1 AA112 PHE A 56 TRP A 59 0 SHEET 2 AA112 HIS A 111 ARG A 116 -1 O ARG A 115 N GLU A 57 SHEET 3 AA112 LEU A 122 ARG A 134 -1 O LEU A 123 N VAL A 114 SHEET 4 AA112 ARG A 161 VAL A 171 -1 O GLU A 165 N VAL A 129 SHEET 5 AA112 ALA A 200 ALA A 204 1 O VAL A 201 N CYS A 164 SHEET 6 AA112 GLY A 393 TYR A 404 -1 O TYR A 402 N TYR A 202 SHEET 7 AA112 ALA A 213 SER A 221 -1 N HIS A 219 O GLY A 393 SHEET 8 AA112 VAL A 374 VAL A 378 -1 O MET A 377 N PHE A 218 SHEET 9 AA112 LEU A 340 ALA A 351 1 N ALA A 344 O ASN A 376 SHEET 10 AA112 LYS A 318 VAL A 332 -1 N TYR A 326 O TYR A 345 SHEET 11 AA112 VAL A 308 ASN A 315 -1 N VAL A 313 O ASP A 321 SHEET 12 AA112 LEU A 264 GLU A 266 -1 N ARG A 265 O VAL A 312 SHEET 1 AA210 PHE A 88 PHE A 90 0 SHEET 2 AA210 LYS A 318 VAL A 332 -1 O THR A 331 N ARG A 89 SHEET 3 AA210 LEU A 340 ALA A 351 -1 O TYR A 345 N TYR A 326 SHEET 4 AA210 VAL A 374 VAL A 378 1 O ASN A 376 N ALA A 344 SHEET 5 AA210 ALA A 213 SER A 221 -1 N PHE A 218 O MET A 377 SHEET 6 AA210 GLY A 393 TYR A 404 -1 O GLY A 393 N HIS A 219 SHEET 7 AA210 ALA A 200 ALA A 204 -1 N TYR A 202 O TYR A 402 SHEET 8 AA210 ARG A 161 VAL A 171 1 N CYS A 164 O VAL A 201 SHEET 9 AA210 LEU A 122 ARG A 134 -1 N VAL A 129 O GLU A 165 SHEET 10 AA210 GLY A 289 PRO A 290 -1 O GLY A 289 N ARG A 134 CISPEP 1 PRO A 209 THR A 210 0 -11.10 SITE 1 AC1 35 HIS A 12 ALA A 13 PHE A 14 TRP A 15 SITE 2 AC1 35 ASN A 79 TYR A 80 VAL A 81 PHE A 168 SITE 3 AC1 35 LEU A 169 CYS A 170 VAL A 171 ARG A 176 SITE 4 AC1 35 GLU A 177 LYS A 178 ARG A 179 LEU A 180 SITE 5 AC1 35 ALA A 181 PRO A 182 THR A 189 VAL A 192 SITE 6 AC1 35 ASN A 193 TRP A 198 ALA A 200 TYR A 202 SITE 7 AC1 35 THR A 203 LEU A 208 TYR A 404 HOH A 645 SITE 8 AC1 35 HOH A 655 HOH A 665 HOH A 671 HOH A 691 SITE 9 AC1 35 HOH A 724 HOH A 737 HOH A 789 SITE 1 AC2 17 ASP A 83 PHE A 88 PHE A 90 ASN A 167 SITE 2 AC2 17 THR A 203 GLY A 205 TYR A 217 HIS A 219 SITE 3 AC2 17 SER A 330 ASN A 376 GLY A 395 ASP A 396 SITE 4 AC2 17 GLY A 397 LEU A 421 HOH A 603 HOH A 604 SITE 5 AC2 17 HOH A 641 CRYST1 48.309 89.934 52.884 90.00 114.74 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020700 0.000000 0.009537 0.00000 SCALE2 0.000000 0.011119 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020820 0.00000